Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CTSB | P07858 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.44 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10964124 | 0.89 | ALDH1A1 (0.67) | ALDH1A1TDP1CTSBL3MBTL1AR | |
| SCHEMBL9468792 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TDP1CTSBL3MBTL1GAA | |
| SCHEMBL9468793 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TDP1CTSBL3MBTL1LMNA | |
| SCHEMBL28307481 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TDP1CTSBL3MBTL1CYP19A1 | |
| SCHEMBL7788656 | 0.82 | TDP1 (0.80) | ALDH1A1TDP1CTSBARLMNA | |
| SCHEMBL28428409 | 0.81 | TDP1 (0.60) | ALDH1A1TDP1CTSBL3MBTL1CYP19A1 | |
| SCHEMBL7705373 | 0.81 | ALDH1A1 (0.58) | ALDH1A1TDP1CTSBL3MBTL1AR | |
| SCHEMBL29079739 | 0.80 | PDGFRA (0.56) | — | |
| SCHEMBL27740333 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TDP1CTSBARLMNA | |
| SCHEMBL8321793 | 0.79 | TDP1 (0.52) | ALDH1A1TDP1CTSBARCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163968-B2 | Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers | BIO-RAD LABORATORIES, INC. (US) | 2024-12-10 | — | — | US | claimed |
| CN-114773201-A | Method for rapidly preparing 1-methoxy-4-nitronaphthalene based on micro-channel continuous flow technology | 都创(上海)医药开发有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-110590558-A | Method for catalyzing selective nitration of 1-methoxynaphthalene by using zeolite molecular sieve | 蚌埠学院 | 2019-12-20 | — | — | CN | claimed |
| EP-2486115-B1 | ELECTRORHEOLOGIC FLUID COMPRISING ORGANIC SUBSTANCES THAT CAN BE DOPED AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2015-05-20 | — | — | EP | claimed |
| EP-2486115-A1 | ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF | Fraunhofer Gesellschaft zur Förderung der angewandten Wissenschaft E.V. (DE) | 2012-08-15 | — | — | EP | claimed |
| WO-2011042117-A1 | ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2011-04-14 | — | — | WO | claimed |
| EP-1037873-B1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | CONSORTIUM ELEKTROCHEM IND (DE) | 2001-08-22 | — | — | EP | claimed |
| US-6211410-B1 | PARTIALLY HYDROGENATING ORGANIC NITRO COMPOUND IN PRESENCE OF ORGANIC BASE OR AMMONIA, TRIVALENT PHOSPHORUS COMPOUND AND HYDROGENATION CATALYST | Consortium für elektrochemische Industrie GmbH (DE) | 2001-04-03 | — | — | US | claimed |
| EP-1037873-A1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | Consortium für elektrochemische Industrie GmbH (DE) | 2000-09-27 | — | — | EP | claimed |
| WO-1999028289-A1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | Consortium für elektrochemische Industrie GmbH (DE) | 1999-06-10 | — | — | WO | claimed |
| US-12163968-B2 | Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers | BIO-RAD LABORATORIES, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| CN-116535340-A | Substituted N-aryl-1-naphthylamine compound, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-08-04 | — | — | CN | disclosed |
| US-11712680-B2 | Process for reducing aromatic nitro compounds with supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-08-01 | — | — | US | disclosed |
| EP-4208021-A1 | PREPARATION OF NUCLEATED RBC (NRBC) ANALOGS FOR USE AS REFERENCE HEMATOLOGY CONTROLS IN AUTOMATED HEMATOLOGY ANALYZERS | Bio-Rad Laboratories, Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| CN-116097093-A | Preparation of Nucleated RBC (NRBC) analogs for use as reference blood controls in automated blood analyzers | 生物辐射实验室股份有限公司 | 2023-05-09 | — | — | CN | disclosed |
| WO-1992014697-A1 | SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1992-09-03 | — | — | WO | disclosed |
| US-4962198-A | Process for the hydroxylation of electrophilic aromatic compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-09 | — | — | US | disclosed |
| US-4960950-A | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0352563-A2 | Process for the hydroxylation of electrophilic aromatic compounds | BAYER AG (DE) | 1990-01-31 | — | — | EP | disclosed |
| EP-0335274-A2 | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11712680-B2 | Process for reducing aromatic nitro compounds with supported catalyst | ARG2, NDUFS5, NDUFS7 | ALDH1A1 2712/4885TDP1 2491/4885CTSB 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.